17 ms·
> [monthly] $43,354.73 That's half a million per year. At that price, unless syprine's manufacturing process requires digging diamonds, one could probably save
by toyg 7y ago
> [monthly] $43,354.73
That's half a million per year. At that price, unless syprine's manufacturing process requires digging diamonds, one could probably save money by hiring a dedicated chemist (100k p/y or thereabout) and giving them the necessary money to make the drug just for one.
If I were an insurance company, I'd consider buying a small pharma outfit and target it at these orphan drugs just to save money.
- consp 7y agoI'm no chemist but the stuff doesn't look too complicated. And noting the stuff used to cost far less ...[1] [1] https://en.wikipedia.org/wiki/Triethylenetetramine https://en.wikipedia.org/wiki/Triethylenetetramine
- greatpatton 7y agoAs a chemist you won't even bother to do the synthesis. You just order it from Sigma-Aldrich. Currently it cost about 300$ for 100g.
- yread 7y agoNot a chemist but in NL S-A shows 33,50 eur/100g (ships today!) https://www.sigmaaldrich.com/catalog/product/aldrich/132098?lang=en®ion=NL https://www.sigmaaldrich.com/catalog/product/aldrich/132098?...
- jonlucc 7y agoAs I'm sure you know but so that others understand, that's technical grade, not pharmaceutical grade.
- sigmahead 7y agoInteresting! However on Sigma-Aldrich website it says: technical grade, 60% How do you get from 60% to 99%? Do you have to (for pharmaceutical grade)? What are the remaining 40%? poison? harmless byproducts?
- greatpatton 7y agoYou can buy the 97% version. Then a quick analysis (IR specter, NMR) will give you an idea of the contaminants if they are not specified by the manufacturer. Based on that you can take additional step to purify the product (extraction, chromatography, etc.) to the required level. The yield may not be perfect making overall cost a little bit higher, but this is really basic organic chemistry.
- Aromasin 7y agoIs there any law as to purchasing/producing unregulated drugs in the US? If not, I'm surprised some budding pharmaceutical chemist hasn't swooped in and started producing these sorts of drugs. You know, free market capitalism and all that.
- cultus 7y agoI don't believe so. There are foreign online pharmacies of various reliability that a good number of people use. Folks near the border go up to Canada as well. None of that is legal, but it's not enforced. I imagine the outcry would be too great.
- kokojie 7y agoYou can produce the drugs but very hard to get anyone to buy it, as your product is not recognized by pharmacies and insurance companies as legitimate. Drugs doesn't get bought in the US unless it is carried by pharmacies and pharmacies won't carry your prescription drug unless insurance covers it.
- Aromasin 7y agoAll I'm thinking is that there's likely some very desperate people out there looking very hard for these drugs in a cheaper form, and with a bit of viral marketing magic from the pharmacist I don't think it would be a massive stretch to match the two.
- philipkglass 7y agoIt wouldn't be hard except for FDA regulations around manufacturing/selling drugs intended for human use. Ah, so we should just get rid of those regulations and let the little guy compete! Not so fast. Maybe the first new market entrants are motivated by altruism as much as by profit. They do everything carefully but charge prices closer to cost. Patients pay less and there are hardly any downsides, except to the financials of legacy pharma companies. But by year 3 there are people who have learned that you can buy barrels of technical-grade active pharmaceutical ingredients off of Alibaba and make pills from them without any quality control in between. Sometimes the products are contaminated with carcinogens. Sometimes they vary widely in potency across lot numbers. In the absence of regulations, fraudulent and shoddy products become widespread. It would be like the supplements industry, except that people actually die if they don't take real prescription drugs they need (this is less common for people who are sold fake herbs.)
- gus_massa 7y agoTranslation of https://en.wikipedia.org/wiki/Triethylenetetramine#Production https://en.wikipedia.org/wiki/Triethylenetetramine#Productio... (with some personal remarks): It's not easy to put that Nitrogens in the middle of the chain. Moreover, the method to produce it is to mix some smaller chains that have the Nitrogen in the ends of the chain and make them combine in a longer chain. This produces a mix of a lot of similar chains with different length and number of Nitrogen. They have similar properties, so it is difficult to separate them. They use distillation. But at high temperature that Nitrogens like to burn, so heat the mix carefully. Also, the mix you produce have a lot of compounds with the same "2D" formula, but they have a different shape in "3D". Some of the versions may have totally different properties, like been very toxic. So you must separate them too, and again, it's difficult. Note: I studied a Chemistry specialization in the Secondary School, so I have some general knowledge about this, but I'm far from an expert in medical drug production. Note 2: If you like this kind of things, I recommend to see the Nile Red channel in YouTube https://www.youtube.com/channel/UCFhXFikryT4aFcLkLw2LBLA https://www.youtube.com/channel/UCFhXFikryT4aFcLkLw2LBLA It's nice to see some easy and not so easy projects, and he explain the reactions, and the problems and pitfalls he found. (I don't understand everything he does.) --- Anyway, the difference of the cost of the medical drug and the chemistry drug is annoying.
- dariusj18 7y agoInteresting point about insurance companies saving money that way. I know that some insurance companies are starting to run medical practices and pharmacies, I wonder how far away them making their own drugs is. Unfortunately, I fear that that's the direction of further distopia.
- vonmoltke 7y ago> I know that some insurance companies are starting to run medical practices and pharmacies They are? Where is this happening? This could be a good thing, but I doubt it since the regulations on such entities will likely be warped in their favor.
- cmiles74 7y agoAetna owns with CVS. https://prospect.org/article/why-aetna-and-cvs-merger-so-dangerous https://prospect.org/article/why-aetna-and-cvs-merger-so-dan...
- _eht 7y agoRite aid is currently piloting RediClinic which will be basically a mix between yoga classes and urgent care. Essentially they want to get you having more than your blood pressure checked and enjoy some other things they can throw at your insurance.
- MichaelApproved 7y agoKaiser Permanente is doing that in California. I was very happy with their healthcare when I lived there.
- xzel 7y agoAs well as Colorado where, to my understanding, use a hospital to house their own doctors and their own pharmacy (not sure if they own the hospital).
- learc83 7y agoSame in Georgia. I loved Kaiser (but my current employer doesn't offer it). It was great being able to go to one facility to see a doctor, a specialist, get tests, and fill a prescription.
- Xelbair 7y agoSadly it is not about how much manufacturing and research costs. But about how much they can profit from it.
- toyg 7y agoI agree, I was just noticing that such a ridiculous margin should allow for other actors to step in at lower price points. Maybe maire's sister does not have half a mil lying around to kickstart the experiment, but with these numbers, sooner or later someone likely will.
- inflatableDodo 7y ago>Maybe maire's sister does not have half a mil lying around to kickstart the experiment The set of people with the condition probably does. I wonder if a kickstarter for generics would be successful?
- nroach 7y agoThe disincentive to new entrants is that the existing market participants can always drop prices enough to make the new entrant unprofitable. If you're in a control of a monopoly or oligopoly, you monitor for signs of new entrants, and when they begin to raise or deploy capital, you offer to buy them out or drop your prices to unsustainable levels and wait for the new entrant to run out of capital.
- aeorgnoieang 7y agoI'm sure there are other barriers as, if what you are describing is complete, one could earn a pretty riskless profit by some combination of (a) 'threatening' to become a new entrant in the market for an expensive drug; (b) stockpiling the existing entrants drugs when they drop their price to try to drive you out of business. I remember reading a book about the history of some (famous) chemical company in the U.S. – Dow? Dupont? – doing exactly what I described to compete with the at-the-time existing German chemical company cartel.
- liveoneggs 7y agoYou might not need to hire one if a compounding pharmacy can handle it
- staticautomatic 7y agoCompounding pharmacies don't make drugs, they mix them.
- candiodari 7y agoThis is something pharmacies did in the past.
- nathanvanfleet 7y agoSo you're imagining the insurance companies aren't somehow benefitting from the high cost of healthcare?
- BurningFrog 7y agoThe real manufacturing cost is of course lower than the old $177/month cost. These cases from the last 1-2 decades are always because of FDA regulations. The drug is out of patent, any manufacturer is allowed to make it, but the FDA regulations for actually starting up manufacturing are so difficult and time consuming that whoever is left as the only manufacturer of a rare drug can crank up the price from $177 to $43k, and ride on that profit wave for a few years while FDA processes competitors applications. More sad detail here: https://slatestarcodex.com/2015/09/24/the-problems-with-generic-medications-go-deeper-than-one-company/ https://slatestarcodex.com/2015/09/24/the-problems-with-gene...
- btilly 7y agoIf I were an insurance company, I'd consider buying a small pharma outfit and target it at these orphan drugs just to save money. Here is why you'd rethink that position. By law, insurance companies have to spend 80-85% of their revenue on patient care. Which means that their potential profits are limited by medical expenses paid out. As long as they have properly projected and accounted for the medical expenses in their business model, they therefore have a financial incentive to let expenses be high.
- kurthr 7y agoYes, insurance companies are not on your side. They want all prices to rise so their competitors pay the same... and we wonder why there is price fixing?
- JamesBarney 7y agoBut then their rates wouldn't be competitive and people would switch insurance.
- burnte 7y agoThe pharma company is a standalone subsidiary, the insurance company is the only customer. The profits they keep go to the shareholders, bypassing the 85% rule.
- BurningFrog 7y agoThat might be a decent argument for another discussion. Spending $43,354 for something and getting a $30 copay in return will never be a part of any clever scheme to fleece anyone.
- drewcoo 7y ago> unless syprine's manufacturing process requires digging diamonds In a way, it does. Diamonds also have inflated value due to forced scarcity.
- tastygreenapple 7y ago> If I were an insurance company, I'd consider buying a small pharma outfit and target it at these orphan drugs just to save money. I've looked into it but the regulations get in the way. It's a crock of bologna - if you hire an American Chemist and set up an American chemical plant, you have to build the facility and wait for FDA inspection before you can start manufacturing and in some cases, you have to pay for a trial to prove that your medication works. Or you can just import the drug from China and India and the FDA will let you act like a compounding pharmacy and repackage the Chinese / Indian active ingredients. Then you have to pay the licensing fees which are borne equally by all manufacturers. If you make 100 doses/yr, you pay as much as your competitor who makes 1 billion doses/yr. There's a reason the market for easily-produced medication hasn't been disrupted yet, if you make affordable high quality medications in a way that doesn't defer to the FDA's stupid system, you can and will go to prison.
- esyir 7y agoSo TL;DR, prices are high because of poorly done / too much regulation?